MAGA, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 966
EU - Europa 681
AS - Asia 131
OC - Oceania 1
SA - Sud America 1
Totale 1.780
Nazione #
US - Stati Uniti d'America 964
IE - Irlanda 188
GB - Regno Unito 187
CN - Cina 95
SE - Svezia 74
IT - Italia 55
UA - Ucraina 55
FR - Francia 39
DE - Germania 36
FI - Finlandia 15
SG - Singapore 10
BE - Belgio 7
TR - Turchia 7
VN - Vietnam 7
CZ - Repubblica Ceca 6
RU - Federazione Russa 6
IN - India 5
IR - Iran 4
NL - Olanda 3
DK - Danimarca 2
ES - Italia 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CA - Canada 1
CH - Svizzera 1
JP - Giappone 1
KH - Cambogia 1
LK - Sri Lanka 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.780
Città #
Dublin 180
Southend 174
Fairfield 146
Chandler 103
Ashburn 85
Houston 64
Wilmington 58
Seattle 57
Cambridge 54
Ann Arbor 51
Jacksonville 51
Woodbridge 51
Menlo Park 39
Siena 31
Beijing 27
Princeton 26
New York 22
Dearborn 17
Nanjing 12
Shanghai 11
San Diego 8
Boardman 7
Brussels 7
Dong Ket 7
Fremont 7
Helsinki 7
Izmir 6
Lancaster 6
Moscow 6
Singapore 6
Washington 6
Düsseldorf 5
Jiaxing 5
Nanchang 5
Tianjin 5
Changsha 3
Jinan 3
San Mateo 3
Agliana 2
Bologna 2
Brno 2
Hebei 2
Leawood 2
Los Angeles 2
Málaga 2
Ningbo 2
Olomouc 2
Paris 2
Pavia 2
Redwood City 2
Shenyang 2
Taizhou 2
Utrecht 2
Zanjan 2
Bangalore 1
Bratislava 1
Briey 1
Canberra 1
Changchun 1
Chengdu 1
Colombo 1
Edinburgh 1
Florence 1
Frankfurt am Main 1
Frederiksberg 1
Gunzenhausen 1
Hangzhou 1
Hefei 1
Hounslow 1
Kunming 1
Lanzhou 1
London 1
Mainz 1
Minsk 1
Napoli 1
Norwalk 1
Oklahoma City 1
Palermo 1
Phnom Penh 1
Phoenix 1
Poggibonsi 1
Prague 1
Qingdao 1
Rome 1
San Francisco 1
Sofia 1
Tokyo 1
Toronto 1
Venezia 1
Waltham 1
Warsaw 1
Wernigerode 1
Xian 1
Zhengzhou 1
Zurich 1
Totale 1.434
Nome #
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma. 186
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 177
DDX3X Helicase Inhibitors as a New Strategy to Fight the West Nile Virus Infection 171
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 150
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X 148
Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors 147
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 142
Parallel solution phase synthesis of 4-dialkylamino-2-methylsulfonyl-6-vinylpyrimidines 141
Specific Targeting of Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. 2. Stereoselective Interaction to Overcome the Effects of Drug Resistant Mutations 124
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 117
HCV-targeted Antivirals: Current Status and Future Challenges 101
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity 89
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO[3,4-D PYRIMIDINE AND PYRROLO[2,3-D]PYRIMIDINE AND USES THEREOF | [NOUVEAUX DÉRIVÉS 4-SUBSTITUÉS DE LA PYRAZOLO[3,4-D]PYRIMIDINE ET DE LA PYRROLO[2,3-D]PYRIMIDINE ET LEURS UTILISATIONS] 51
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO[3,4-D PYRIMIDINE AND PYRROLO[2,3-D]PYRIMIDINE AND USES THEREOF 47
Towards Innovative Antibacterial Correctors for Cystic Fibrosis Targeting the Lung Microbiome with a Multifunctional Effect 16
Totale 1.807
Categoria #
all - tutte 5.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020400 42 14 22 61 31 48 42 46 31 33 13 17
2020/2021230 9 25 9 23 6 49 9 31 21 18 13 17
2021/2022214 11 35 8 10 8 9 13 13 18 18 25 46
2022/2023307 17 49 39 36 30 54 11 23 30 6 11 1
2023/2024295 4 6 21 12 12 91 107 18 0 10 0 14
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 1.807